jbh492

Jbh492 has been investigated in 1 clinical trial, of which 1 is open and 0 are closed. Of the trial investigating jbh492, 1 is phase 1 (1 open).

Chronic lymphocytic leukemia and non-hodgkin lymphoma are the most common diseases being investigated in jbh492 clinical trials [2].

Synonyms [2]:

jbh-492, jbh 492, anti-ccr7 adc jbh492

Drug Target(s) [2]:

CCR7

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].

2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.